2-Fluoro-1,3-dimethylimidazolidinium hexafluorophosphate

We are 2-Fluoro-1,3-dimethylimidazolidinium hexafluorophosphate CAS:164298-27-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Fluoro-1,3-dimethylimidazolidinium hexafluorophosphate
CAS.NO:164298-27-5
Synonyms:1,3-Dimethyl-2-fluoroimidazolidinium hexafluorophosphate;DFIH
Molecular Formula:C5H10F7N2P
Molecular Weight:262.10900
 
Physical and Chemical Properties:
Melting point:162-167oC;
 
Specification:
Appearance:White crystal powder
Purity(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent

2-Fluoro-1,3-dimethylimidazolidinium hexafluorophosphate


Related News: The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.2-(4-chlorophenyl)hexanenitrile The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.3-BAEPF CAS:1260032-45-8 Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.5070-13-3 At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.

Related Products
Product Name
D-Phenylglycine View Details
N-Me-4-methoxy-L-phenylalanine View Details
Boc-4-nitro-L-phenylalanine View Details
(S)-3-Acetylthio-2-methylpropionyl-L-proline manufacturer trifluoroacetyl chloride manufacturer 2-Chloro-5-nitropyridine manufacturer 3-Hydroxy-3′-nitro-2-naphthanilide manufacturer 3-trifluoromethylbenzoic acid manufacturer